IL23A anticorps (C-Term)
Aperçu rapide pour IL23A anticorps (C-Term) (ABIN499996)
Antigène
Voir toutes IL23A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- This antibody reacts to IL-23.
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogène
- IL-23 antibody was raised against a 14 amino acid peptide from near the carboxy terminus of human IL-23.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
ELISA. Western BLot: 2 - 4 μg/mL. Immunocytochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
-
- IL23A (Interleukin 23, alpha subunit p19 (IL23A))
-
Autre désignation
- Interleukin-23 alpha / IL23A
-
Sujet
- Like interleukin-27 (IL-27), IL-23 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the IL-12p40 subunit and a novel p19 subunit. IL-23 is secreted by activated dendritic cells, macrophages, and monocytes. Its biological activities include enhancing the proliferation of memory T cells and the production of IFN-gamma, IL-12, and TNF-alpha from activated T cells, and can stimulate macrophages to produce TNF-alpha and nitric oxide. It has also been shown to possess potent anti-tumor and anti-metastatic activity in mouse models of cancer, suggesting a potential role for IL-23 in therapeutic treatment of cancer.Synonyms: IL-23 subunit alpha, IL-23p19, Interleukin-23 subunit p19, SGRF
-
ID gène
- 51561
-
UniProt
- Q9NPF7
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Activated T Cell Proliferation
Antigène
-